Clements Ian 4
4 · Mirum Pharmaceuticals, Inc. · Filed Sep 10, 2019
Insider Transaction Report
Form 4
Clements Ian
SVP Finance & Communications
Transactions
- Purchase
Common Stock
2019-09-06$11.07/sh+1,801$19,937→ 1,801 total - Purchase
Common Stock
2019-09-06$11.87/sh+2,199$26,102→ 4,000 total
Footnotes (2)
- [F1]The weighted average purchase price for the transaction reported was $11.07, and the range of prices were between $10.70 and $11.50. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F2]The weighted average purchase price for the transaction reported was $11.87, and the range of prices were between $11.77 and $11.8799. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.